MESA LABORATORIES INC /CO/ 8-K

What Happened
Mesa Laboratories, Inc. announced a leadership transition on March 3, 2026: President and CEO Gary Owens will depart effective on or about April 13, 2026, and the Board has appointed Dr. Siddhartha Kadia as the Company’s new President and Chief Executive Officer and as a Board member effective the same date. Mr. Owens’ separation is not due to any disagreement with the Company. Dr. Kadia (age 56) was chosen after a comprehensive external search and brings more than 20 years of experience in life sciences and diagnostics, most recently serving as CEO of Calibre Scientific (since Jan 2025) and previously serving as CEO of PhenomeX/Berkeley Lights, EAG Laboratories, and holding senior roles at Life Technologies. He holds a Ph.D. in Biomedical Engineering from Johns Hopkins.

Key Details

• Transition announced March 3, 2026; expected Effective/Transition Date: on or about April 13, 2026.
• Employment Agreement dated March 3, 2026: base salary $850,000 per year.
• Incentive pay: eligible for annual cash bonus opportunity of at least 100% of base salary (subject to plan and performance targets).
• Equity package at hire: RSUs with estimated value $3.0 million (vest 1/3 on each of the first three anniversaries) and PSUs with estimated target value $3.0 million (0–200% payout based on performance, vesting after three years). Agreement includes customary severance and other terms.

Why It Matters
A CEO change is a material governance event that can affect strategy, execution and investor expectations. The disclosed pay mix — a sizable equity grant plus a performance-linked PSU program and a large cash-bonus opportunity — ties the new CEO’s pay to multi-year performance, signaling the Board’s focus on aligning leadership incentives with company results. Dr. Kadia’s sector experience may influence Mesa’s strategic direction in life sciences and diagnostics; investors should note the effective date and review subsequent filings for any additional details or changes to guidance, strategy or executive compensation.